Velan Capital Investment Management LP
Filing Date
Global Rank
#4,842
/ 8,420
▲ 899
Top Industry
Biotechnology
89.3%
3Y Alpha vs SPY
+0.9%
Period ended 6 months ago
Filed Feb 13, 2026 · 4mo
17 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+80.3%
SPY
+76.3%
Annualised alpha
+0.9%
Max drawdown
−54.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
42 positions · as of Dec 31, 2025 · Δ vs Sep 30, 2025Top Position
20.4%
+8.3 pts
Top 5
51.2%
+6.1 pts
Top 10
71.0%
−1.6 pts
HHI
805
Diversified+163
Portfolio Trend
17 quarters · across all stocks
Sector Breakdown
As of Dec 31, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $145,346,407 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
4 positions
Trimmed
Positions the filer reduced
5 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | −48,000 | 13,000 | $105,820 | |
| PRAX | Praxis Precision Medicines, Inc. | −32,024 | 100,781 | $29,704,191 | |
| MLYS | Mineralys Therapeutics, Inc. | −24,600 | 151,000 | $5,479,790 | |
| PYXS | Pyxis Oncology, Inc. | −15,000 | 40,000 | $46,000 | |
| REPL | Replimune Group, Inc. | −5,000 | 15,000 | $145,800 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | 522,305 | $9,174,286 | |
| EVMN | Evommune, Inc. | 506,754 | $8,675,628 | |
| ESPR | Esperion Therapeutics, Inc. | 1,210,000 | $4,477,000 | |
| VRCA | Verrica Pharmaceuticals Inc. | 471,559 | $3,918,655 | |
| STRO | Sutro Biopharma, Inc. | 312,000 | $3,609,840 | |
| PROF | Profound Medical Corp. | 285,710 | $2,248,537 | |
| KZIA | Kazia Therapeutics Ltd | 300,000 | $2,067,000 | |
| XLO | Xilio Therapeutics, Inc. | 170,000 | $1,523,200 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
10 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ZOOZ | ZOOZ Strategy Ltd. | 2,000,000 | $4,280,000 | |
| ALMS | Alumis Inc. | 946,683 | $3,777,265 | |
| QURE | uniQure N.V. | 32,000 | $1,867,840 | |
| TELA | TELA Bio, Inc. | 747,410 | $1,113,640 | |
| ELDN | Eledon Pharmaceuticals, Inc. | 346,973 | $898,660 | |
| ALEC | Alector, Inc. | 55,000 | $162,800 | |
| ERAS | Erasca, Inc. | 65,000 | $141,700 | |
| WVE | Wave Life Sciences Ltd. | 15,000 | $109,800 | |
| GERN | Geron Corp | 80,000 | $109,600 | |
| ACRS | Aclaris Therapeutics, Inc. | 32,700 | $62,130 | |
| No positions match the current search. | ||||
42 positions ·
$145,346,407 total
· as of Dec 31, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 100,781 | $29,704,191 | 20.44% | |
| TARA |
Protara Therapeutics, Inc.
Healthcare
|
Added | 2,834,652 | $15,108,695 | 10.39% | |
| HRTX |
Heron Therapeutics, Inc. /De/
Healthcare
|
Held | 8,753,290 | $11,379,277 | 7.83% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
NEW | 522,305 | $9,174,286 | 6.31% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 67,000 | $9,035,285 | 6.22% | |
| EVMN |
Evommune, Inc.
Healthcare
|
NEW | 506,754 | $8,675,628 | 5.97% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Reduced | 151,000 | $5,479,790 | 3.77% | |
| LNTH |
Lantheus Holdings, Inc.
Healthcare
|
Added | 74,687 | $4,970,419 | 3.42% | |
| JSPR |
Jasper Therapeutics, Inc.
Healthcare
|
Held | 2,668,395 | $4,883,162 | 3.36% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Held | 263,642 | $4,787,738 | 3.29% | |
| ESPR |
Esperion Therapeutics, Inc.
Healthcare
|
NEW | 1,210,000 | $4,477,000 | 3.08% | |
| VRCA |
Verrica Pharmaceuticals Inc.
Healthcare
|
NEW | 471,559 | $3,918,655 | 2.70% | |
| NSPR |
InspireMD, Inc.
Healthcare
|
Held | 2,143,698 | $3,815,782 | 2.63% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
NEW | 312,000 | $3,609,840 | 2.48% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Added | 70,000 | $2,828,000 | 1.95% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Held | 130,000 | $2,731,300 | 1.88% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Held | 86,500 | $2,691,880 | 1.85% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
Held | 352,000 | $2,657,600 | 1.83% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 205,000 | $2,566,600 | 1.77% | |
| PROF |
Profound Medical Corp.
Healthcare
|
NEW | 285,710 | $2,248,537 | 1.55% | |
| KZIA |
Kazia Therapeutics Ltd
Healthcare
|
NEW | 300,000 | $2,067,000 | 1.42% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
Held | 750,000 | $1,770,000 | 1.22% | |
| XLO |
Xilio Therapeutics, Inc.
Healthcare
|
NEW | 170,000 | $1,523,200 | 1.05% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Held | 83,333 | $1,015,829 | 0.70% | |
| EDSA |
Edesa Biotech, Inc.
Healthcare
|
Held | 687,500 | $976,250 | 0.67% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Held | 6,500 | $431,535 | 0.30% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Held | 80,000 | $340,800 | 0.23% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 3,700 | $323,158 | 0.22% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Held | 16,000 | $303,520 | 0.21% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
Held | 160,000 | $260,800 | 0.18% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
Held | 70,000 | $217,000 | 0.15% | |
| IMNM |
Immunome Inc.
Healthcare
|
Held | 10,000 | $214,800 | 0.15% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Held | 20,000 | $187,600 | 0.13% | |
| IMMX |
Immix Biopharma, Inc.
Healthcare
|
Held | 35,000 | $183,050 | 0.13% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Held | 100,000 | $147,000 | 0.10% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
Reduced | 15,000 | $145,800 | 0.10% | |
| LRMR |
Larimar Therapeutics, Inc.
Healthcare
|
Held | 33,000 | $125,730 | 0.09% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
|
Reduced | 13,000 | $105,820 | 0.07% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Held | 45,000 | $90,900 | 0.06% | |
| DTIL |
Precision Biosciences Inc
Healthcare
|
Held | 20,000 | $83,200 | 0.06% | |
| PYXS |
Pyxis Oncology, Inc.
Healthcare
|
Reduced | 40,000 | $46,000 | 0.03% | |
| PMVP |
PMV Pharmaceuticals, Inc.
Healthcare
|
Held | 35,000 | $43,750 | 0.03% |